Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMC Injection for Chronic Lower Back Pain
NCT04559295Phase 3Unknown
- Sponsor
- StemCures
- Start
- Nov 2018
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of autologous bone marrow cell concentrate in chronic low back pain (CLBP), intervertebral disc degeneration (DDD), radiculopathy and 3 more (2 arms), sponsored by StemCures. Primary endpoint: Oswestry Disability Index at 2 years. Status: unknown.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
chronic low back pain (CLBP)intervertebral disc degeneration (DDD)radiculopathyspinal stenosisfacet joint osteoarthritis
Beyond the preview
Go deeper on NCT04559295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04559295.